SFG
RLAY icon

Steward Financial Group’s Relay Therapeutics RLAY Stock Holding History

Steward Financial Group’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$0 Buy
+7
New +$75 ﹤0.01% 1524
2023
Q2 		– Sell
-23
Closed – – 892
2023
Q1 		$0 Buy
23
+15
+188% +$269 ﹤0.01% 881
2022
Q4 		$0 Buy
+8
New +$153 ﹤0.01% 771
2022
Q3 		– Sell
-8
Closed – – 1052
2022
Q2 		$0 Buy
+8
New +$171 ﹤0.01% 1307

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Steward Financial Group's RLAY Position: Q3 2023 in Review

Steward Financial Group opened a new position in Relay Therapeutics (RLAY) in Q3 2023: 7 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1524 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in RLAY as recently as Q1 2023.

Steward Financial Group first reported a position in RLAY in Q2 2022 and has held it in 4 quarters since. 172 funds tracked by Wall St. Rank hold RLAY as of Q3 2023.

  • Steward Financial Group held 7 shares of Relay Therapeutics worth $0 as of Q3 2023.
  • Relay Therapeutics was a new Steward Financial Group position in Q3 2023.
  • Relay Therapeutics made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #1524 holding.
  • Steward Financial Group first reported a position in Relay Therapeutics in Q2 2022 and has held it in 4 quarters since.
  • 172 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.